Developing and delivering mRNA lipid nanoparticle therapeutics

Örn Almarsson is the Co-Founder and CEO of a startup biopharma company called Axelyf (Hafnarfjörður, Iceland & MA, USA) that is developing lipid technologies to safely and efficiently deliver mRNA therapeutics. Örn previously worked for companies like Merck (PA, USA) and Moderna (MA, USA), where he and his team developed therapeutic delivery systems for mRNA, before co-founding Axelyf. At ELRIG Research & Innovation (10–11 March 2025; London, UK), Örn spoke about mRNA lipid nanoparticle technology for delivering therapeutics in the future. In his talk, he demonstrated that there are ways to deliver therapeutics that produce large proteins like antibodies from...